Source: PR Newswire

Press Release: Specialty Enzymes & Biotechnologies : Specialty Enzymes & Probiotics is pleased to announce SEBtilis received a No Objections Letter from the FDA for its GRAS submission. GRAS stands for Generally Recognized As Safe.

CHINO, Calif., Oct. 25, 2021 /PRNewswire/ -- The GRAS Notification Program is a voluntary submission for products that are intended as food additives. Based on our extensive research, specifications, intended usage, history, preparation, and reports, the GRAS submission for SEBtilis ...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Vic Rathi's photo - President & CEO of SEB

President & CEO

Vic Rathi

CEO Approval Rating

81/100

Read more